EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 32 (2025) OCL, 32 (2025) 36 References
Issue
OCL
Volume 32, 2025
Lipids and health / Lipides et santé
Article Number 36
Number of page(s) 16
DOI https://doi.org/10.1051/ocl/2025032
Published online 28 November 2025
  • Aboud O, Mrak RE, Boop FA, Griffin WS. 2013. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathol Commun 1: 41. [Google Scholar]
  • Al MD, Badart-Smook A, von Houwelingen AC, Hasaart TH, Hornstra G. 1996. Fat intake of women during normal pregnancy: relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr 15 (1): 49–55. [Google Scholar]
  • Al Khayat HA, Awadalla MM, Al Wakad A, Marzook ZA. 2010. Polyunsaturated fatty acids in children with idiopathic intractable epilepsy: Serum levels and therapeutic response. J Pediatr Neurol 8: 175–185. [Google Scholar]
  • Allaman I, Bélanger M, Magistretti PJ. 2011. Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34 (2): 76–87. [CrossRef] [PubMed] [Google Scholar]
  • Amen DG, Harris WS, Kidd PM, Meysami S, Raji CA. 2017. Quantitative erythrocyte omega-3 EPA plus DHA levels are related to higher regional cerebral blood flow on brain SPECT. J Alzheimers Dis 58 (4): 1189–1199. [CrossRef] [PubMed] [Google Scholar]
  • Ames A. 2000. CNS energy metabolism as related to function. Brain Res Rev 34 (1-2): 42–68. [Google Scholar]
  • Andrisse S, Patel GD, Chen JE, et al. 2013. ATM and GLUT1-S490 phosphorylation regulate GLUT1 mediated transport in skeletal muscle. PLoS One (6): e66027. [Google Scholar]
  • Araújo TG, Oliveira AG, Vecina JF, et al. 2016. Treatment with Parkinsonia aculeata combats insulin resistance-induced oxidative stress through the increase in PPARγ/CuZn-SOD axis expression in diet-induced obesity mice. Mol Cell Biochem 419: 93–101. [Google Scholar]
  • Arispe N, Pollard HB, Rojas E. 1993. Giant multilevel cation channels formed by Alzheimer disease amyloid-β protein [AβP-(1-40)] in bilayer membranes. Proc Natl Acad Sci USA 90: 10573–10577. [Google Scholar]
  • Arsov T, Mullen SA, Rogers S, et al. 2012. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 72 (5): 807–815. [Google Scholar]
  • Asztely F, Erdemli G, Kullmann DM. 1997. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron 18 (2): 281–293. [Google Scholar]
  • Attwell D, Laughlin SB. 2001. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21 (10): 1133–1145. [Google Scholar]
  • Bahar S, Suh M, Zhao M, Schwartz TH. 2006. Intrinsic optical signal imaging of neocortical seizures: The “epileptic dip”. Neuroreport 17: 499–503. [Google Scholar]
  • Baiden-Amissah K, Joashi U, Blumberg R, Mehmet H, Edwards AD, Cox PM. 1998. Expression of amyloid precursor protein (beta-APP) in the neonatal brain following hypoxic ischaemic injury. Neuropathol Appl Neurobiol 24 (5): 346–352. [Google Scholar]
  • Barcelo-Coblijn G, Murphy EJ. 2009. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 48 (6): 355–374. [Google Scholar]
  • Bascunana P, Javela J, Delgado M, et al. 2016. [(18)F]FDG PET Neuroimaging Predicts Pentylenetetrazole (PTZ) Kindling Outcome in Rats. Mol Imaging Biol 18 (5): 733–740. [Google Scholar]
  • Bechard E, Arel E, Bride J, et al. 2024. Activation of hTREK-1 by polyunsaturated fatty acids involves direct interaction. Sci Rep 14 (1): 15244. [Google Scholar]
  • Bergamasco B, Benna P, Ferrero P, Gavinelli R. 1984. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 25 (2): 131–136. [Google Scholar]
  • Bergren SK, Chen S, Galecki A, Kearney JA. 2005. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mamm Genome 16 (9): 683–690. [Google Scholar]
  • Bhatia R, Lin H, Lal R. 2000. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J 14 (9): 1233–1243. [Google Scholar]
  • Bode H. 1992. Intracranial blood flow velocities during seizures and generalized epileptic discharges. Eur J Pediatr 151 (9): 706–709. [Google Scholar]
  • Boyd-Kimball D, Sultana R, Poon HF, et al. 2005. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer’s disease. Neuroscience 132 (2): 313–324. [Google Scholar]
  • Brodersen P, Paulson OB, Bolwig TG, Rogon ZE, Rafaelsen OJ, Lassen NA. 1973. Cerebral hyperemia in electrically induced epileptic seizures. Arch Neurol 28 (5): 334–338. [Google Scholar]
  • Bromfield E, Dworetzky B, Hurwitz S, et al. 2008. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12 (1): 187–190. [Google Scholar]
  • Buda O, Arsene D, Ceausu M, Dermengiu D, Curca GC. 2009. Georges Marinesco and the early research in neuropathology. Neurology 72 (1): 88–91. [Google Scholar]
  • Busche MA, Chen X, Henning HA, et al. 2012. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 109 (22): 8740–8745. [Google Scholar]
  • Butterfield DA, Castegna A, Lauderback CM, Drake J. 2002. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiol Aging 23 (5): 655–664. [Google Scholar]
  • Cano A, Fonseca E, Ettcheto M, et al. 2021. Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals (Basel) 14 (10): 1057. [Google Scholar]
  • Capper EA, Marshall LA. 2001. Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 40 (3): 167–197. [CrossRef] [PubMed] [Google Scholar]
  • Caviedes A, Varas-Godoy M, Lafourcade C, et al. 2017. Endothelial nitric oxide synthase is present in dendritic spines of neurons in primary cultures. Front Cell Neurosci 11: 180. [CrossRef] [PubMed] [Google Scholar]
  • Chang EH, Savage MJ, Flood DG, et al. 2006. AMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin mice. Proc Natl Acad Sci USA 103: 3410–3415. [Google Scholar]
  • Cho HP, Nakamura MT, Clarke SD. 1999. Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J Biol Chem 274 (1): 471–477. [CrossRef] [PubMed] [Google Scholar]
  • Chung SS, Kim M, Youn BS, et al. 2009. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Mol Cell Biol 29 (1): 20–30. [Google Scholar]
  • Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. 1980. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4 (2): 121–129. [Google Scholar]
  • Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992 Apr; 120(4 Pt 2): S129–S138. [CrossRef] [PubMed] [Google Scholar]
  • Colom LV, Diaz ME, Beers DR, Neely A, Xie WJ, Appel SH. 1998. Role of potassium channels in amyloid-induced cell death. J Neurochem 70: 1925–1934. [Google Scholar]
  • Corrigan F, Thornton E, Roisman LC, et al. 2014. The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110. J Neurochem 128 (1): 196–204. [Google Scholar]
  • Costa C, Parnetti L, D’Amelio M, et al. 2016. Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? Neurobiol Aging 48: 161–171. [Google Scholar]
  • Couedelo L, Buaud B, Abrous H, Chamekh-Coelho I, Majou D, Boué-Vaysse C. 2022. Effect of increased levels of dietary α-linolenic acid on the n-3 PUFA bioavailability and oxidative stress in rat. Br J Nutr 127 (9): 1320–1333. [Google Scholar]
  • Deckelbaum RJ, Worgall TS, Seo T. 2006. n-3 fatty acids and gene expression. Am J Clin Nutr 83: 1520S–1525S. [CrossRef] [PubMed] [Google Scholar]
  • DeGiorgio CM, Miller PR, Harper R, et al. 2015. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. J Neurol Neurosurg Psychiatry 86 (1): 65–70. [Google Scholar]
  • de Labra C, Rivadulla C, Espinosa N, Dasilva M, Cao R, Cudeiro J. 2009. Different sources of nitric oxide mediate neurovascular coupling in the lateral geniculate nucleus of the cat. Front Syst Neurosci 3: 9. [CrossRef] [PubMed] [Google Scholar]
  • De Simone R, Silvestrini M, Marciani MG, Curatolo P. 1998. Changes in cerebral blood flow velocities during childhood absence seizures. Pediatr Neurol 18 (2): 132–135. [Google Scholar]
  • de Urquiza AM, Liu S, Sjöberg M, et al. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (5499): 2140–2144. [CrossRef] [PubMed] [Google Scholar]
  • Delplanque B. 2017. Acides gras oméga-3 : de l’acide α-linolénique (ALA) à l’acide docosahexaénoïque (DHA). Lipid Nutri+ 34. [Google Scholar]
  • Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280: 17294–17300. [Google Scholar]
  • DiNicolantonio JJ, O’Keefe JH. 2020. The importance of marine omega-3s for brain development and the prevention and treatment of behavior, mood, and other brain disorders. Nutrients 12 (8): 2333. [Google Scholar]
  • Diep QN, Amiri F, Touyz RM, et al. 2002. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40 (6): 866–871. [CrossRef] [PubMed] [Google Scholar]
  • Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. 2001. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer’s disease. J Neurosci 21: 4125–4133. [Google Scholar]
  • Dubrovskaia NM, Nalivaeva NN, Plesneva SA, Feponova AA, Turner AJ, Zhuravin IA. 2009. Changes in the activity of amyloid-degrading metallopeptidases leads to disruption of memory in rats. Zh Vyssh Nerv Deiat Im I P Pavlova 59 (5): 630–638. [Google Scholar]
  • Duncan R. 1992. Epilepsy, cerebral blood flow, and cerebral metabolic rate. Cerebrovasc Brain Metab Rev 4 (2): 105–121. [Google Scholar]
  • Dutta-Roy AK. 2000. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 71(1 Suppl): 315S–22S. [Google Scholar]
  • Dziedzic B, Bewicz-Binkowska D, Zgorzynska E, et al. 2018. DHA upregulates FADS2 expression in primary cortical astrocytes exposed to vitamin A. Physiol Res 67 (4): 663–668. [CrossRef] [PubMed] [Google Scholar]
  • Eckert GP, Chang S, Eckmann J, et al. 2011. Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing. Biochim Biophys Acta 1808 (1): 236–243. [Google Scholar]
  • EFSA. 2010. Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA). EFSA J 8 (10): 1734–1751. [Google Scholar]
  • Elsadek AE, Maksoud YHA, Suliman HA, et al. 2021. Omega-3 supplementation in children with ADHD and intractable epilepsy. J Clin Neurosci 94: 237–243. [Google Scholar]
  • Ferrari D, Cysneiros RM, Scorza CA, et al. 2008. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav 13 (1): 36–42. [Google Scholar]
  • Fisher RS, Cross JH, French JA, et al. 2017. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia 58 (4): 522–530. [Google Scholar]
  • Flood D, Lee ES, Taylor CT. 2023. Intracellular energy production and distribution in hypoxia. J Biol Chem 299 (9): 105103. [Google Scholar]
  • Fol R, Braudeau J, Ludewig S, Abel T, Weyer SW, Roederer JP. 2016. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model. Acta Neuropathol 131: 247–266. [Google Scholar]
  • French JA, Kanner AM, Bautista J, et al. 2004. Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45: 401–409. [Google Scholar]
  • Galea E, Feinstein DL, Reis DJ. 1992. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Nati Acad Sci USA 89 (22): 10945–10949. [CrossRef] [PubMed] [Google Scholar]
  • Garcia-Bueno B, Caso JR, Pérez-Nievas BG, Lorenzo P, Leza JC. 2007. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 32 (6): 1251–1260. [Google Scholar]
  • Gavzan H, Hashemi F, Babaei J, Sayyah M. 2018. A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole. Neurosci Lett 681: 83–86. [Google Scholar]
  • Geng X, Yang B, Li R, et al. 2020. Effects of docosahexaenoic acid and its peroxidation product on amyloid-β peptide-stimulated microglia. Mol Neurobiol 57 (2): 1085–1098. [Google Scholar]
  • Gibson RA, Neumann MA, Makrides M. 1997. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 51 (9): 578–584. [Google Scholar]
  • Glaser C, Lattka E, Rzehak P, Steer C, Koletzko C. 2011. Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr 2011. Suppl 2: 27–40. [Google Scholar]
  • Grilli M, Goffi F, Memo M, Spano P. 1996. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 271 (25): 15002–15007. [Google Scholar]
  • Grimm MO, Haupenthal VJ, Mett J, et al. 2016. Oxidized docosahexaenoic acid species and lipid peroxidation products increase amyloidogenic amyloid precursor protein processing. Neurodegener Dis 16 (1-2): 44–54. [Google Scholar]
  • Harris ME, Wang Y, Pedigo NW Jr, Hensley K, Butterfield DA, Carney JM. 1996. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67 (1): 277–286. [Google Scholar]
  • Hefendehl JK, LeDue J, Ko RW, Mahler J, Murphy TH, MacVicar BA. 2016. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging. Nat Commun 7: 13441. [Google Scholar]
  • Helland IB, Saugstad OD, Saarem K, Van Houwelingen AC, Nylander G, Drevon CA. 2006. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 19 (7): 397–406. [Google Scholar]
  • Heurteaux C, Blondeau N. 2005. Le rôle majeur du canal potassique TREK-1 dans la protection neuronale induite par les oméga-3. OCL 12 (1): 68–77. [Google Scholar]
  • Hoffman DR, Uauy R. 1992. Essentiality of dietary omega 3 fatty acids for premature infants: plasma and red blood cell fatty acid composition. Lipids 27 (11): 886–895. [Google Scholar]
  • Hou X, Li Y, Huang Y, Zhao H, Gui L. 2020. Adenosine Receptor A1-A2a Heteromers Regulate EAAT2 Expression and Glutamate Uptake via YY1-Induced Repression of PPARγ Transcription. PPAR Res 2020: 2410264. [Google Scholar]
  • Huang WJ, Zhang X, Chen WW. 2016. Role of oxidative stress in Alzheimer’s disease. Biomed Rep 4 (5): 519–522. [CrossRef] [PubMed] [Google Scholar]
  • Hwang J, Kleinhenz DJ, Lassègue B, Griendling KK, Dikalov S, Hart CM. 2005. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288 (4): C899–905. [Google Scholar]
  • Ibrahim FAS, Ghebremeskel K, Abdel-Rahman ME, et al. 2018. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy − A randomized, double-blind, placebo-controlled trial. Epilepsy Behav 87: 32–38. [Google Scholar]
  • Innis SM, Dyer RA. 2002. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J Lipid Res 43 (9): 1529–1536. [CrossRef] [PubMed] [Google Scholar]
  • Innis SM. 2005. dEssential fatty acid transfer and fetal development. Placenta Suppl A: S70–75. [Google Scholar]
  • Innis SM, Friesen RW. 2008. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 87 (3): 548–557. [Google Scholar]
  • Innocenti GM, Price DJ. 2005. Exuberance in the development of cortical networks. Nat Rev Neurosci 6 (12): 955–965. [Google Scholar]
  • Inoue I, Goto S, Matsunaga T, et al. 2001. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3–11. [Google Scholar]
  • Isackson PJ, Huntsman MM, Murray KD, Gall CM. 1991. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6 (6): 937–948. [Google Scholar]
  • Ishihara Y, Itoh K, Tanaka M, et al. 2017. Potentiation of 17β-estradiol synthesis in the brain and elongation of seizure latency through dietary supplementation with docosahexaenoic acid. Sci Rep 7 (1): 6268. [Google Scholar]
  • Jacob CP, Koutsilieri E, Bartl J, et al. 2007. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer’s disease. J Alzheimers Dis 11 (1): 97–116. [Google Scholar]
  • Janigro D. 1999. Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 37 (3): 223–232. [Google Scholar]
  • Jiang X, Nardelli J. 2016. Cellular and molecular introduction to brain development. Neurobiol Dis 92(Pt A): 3–17. [Google Scholar]
  • Joutsa J, Rinne JO, Hermann B, et al. 2017. Association between childhood-onset epilepsy and amyloid burden 5 decades later. JAMA Neurol 74 (5): 583–590. [Google Scholar]
  • Joutsa J, Rinne JO, Niemi KJ, et al. 2025. Progression of amyloid accumulation in late adulthood among people with childhood-onset epilepsy. Neurology 104 (3): e210303. [Google Scholar]
  • Juber BA, Jackson KH, Johnson KB, Harris WS, Baack ML. 2017. Breast milk DHA levels may increase after informing women: A community-based cohort study from South Dakota USA. Int Breastfeed J 12: 7. [Google Scholar]
  • Kang SH, Kang M, Han JH, et al. 2023. Independent effect of Aβ burden on cognitive impairment in patients with small subcortical infarction. Alzheimers Res Ther 15 (1): 178. [Google Scholar]
  • Kawahara M, Kuroda Y, Arispe N, Rojas E. 2000. Alzheimer’s beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275: 14077–14083. [Google Scholar]
  • Kayed R, Sokolov Y, Edmonds B, et al. 2004. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279: 46363–46366. [Google Scholar]
  • Ketata I, Ellouz E, Mizouri R. 2024. Impact of prenatal, neonatal, and postnatal factors on epilepsy risk in children and adolescents: a systematic review and meta-analysis. Acta Epileptologica 6 (1). [Google Scholar]
  • Kim JS, Lee YH, Chang YU, et al. 2017. PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells. J Physiol Biochem 73: 49–57. [Google Scholar]
  • Knight EM, Martins IV, Gümüsgöz S, Allan SM, Lawrence CB. 2014. High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging 35 (8): 1821–1832. [Google Scholar]
  • Ko GY, Kelly PT. 1999. Nitric oxide acts as a postsynaptic signaling molecule in calcium/calmodulin-induced synaptic potentiation in hippocampal CA1Pyramidal neurons. J Neurosci 19 (16): 6784–6794. [CrossRef] [PubMed] [Google Scholar]
  • Koletzko B, Lattka E, Zeilinger S, Illig T, Steer C. 2011. Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon longitudinal study of parents and children. Am J Clin Nutr 93 (1): 211–219. [Google Scholar]
  • Kourie JI, Henry CL, Farrelly P. 2001. Diversity of amyloid beta protein fragment [1-40]-formed channels. Cell Mol Neurobiol 21: 255–284. [Google Scholar]
  • Krauss-Etschmann S, Shadid R, Campoy C, et al. 2007. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85 (5): 1392–1400. [Google Scholar]
  • Landmark CJ. 2007. Targets for antiepileptic drugs in the synapse. Med Sci Monit 13 (1): RA1–7. [Google Scholar]
  • Lankinen M, Uusitupa M, Schwab U. 2018. Genes and dietary fatty acids in regulation of fatty acid composition of plasma and erythrocyte membranes. Nutrients 10 (11): 1785. [Google Scholar]
  • Lapillonne A, Jensen CL. 2009. Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids 81 (2-3): 143–150 [Google Scholar]
  • Lattka E, Eggers S, Moeller G, et al. 2010. A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor E LK1. J Lipid Res 51 (1): 182–191. [CrossRef] [PubMed] [Google Scholar]
  • Li G, Bauer S, Nowak M, Norwood B, et al. 2011. Cytokines and epilepsy. Seizure 20 (3): 249–256. [Google Scholar]
  • Li Z, Ding C, Gong X, Wang X, Cui T. 2016. Apolipoprotein E ε4 Allele was associated with Nonlesional mesial temporal lobe epilepsy in Han Chinese population. Medicine (Baltimore) 95 (9): e2894. [Google Scholar]
  • Little W. 1862. On the influence of abnormal parturition, difficult labours and asphyxia neonatorum on the mental and physical condition of the child, especially in relation to deformities. In Phillips J, Boulton P, eds. Transactions of the obstetric society of London. London: Obstetrical Society of London vol. 3, p. 293. [Google Scholar]
  • Liu X, Jang SS, An Z, et al. 2012. Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells. Radiat Oncol J 30: 88–95. [Google Scholar]
  • Magistretti PJ, Pellerin L. 1997. Metabolic coupling during activation. A cellular view. Adv Exp Med Biol 413: 161–166. [Google Scholar]
  • Majou D. 2018. Evolution of the human brain: the key roles of DHA (omega-3 fatty acid) and Δ6-desaturase gene. OCL 25 (4): A401. [CrossRef] [EDP Sciences] [Google Scholar]
  • Majou D. 2021. Synthesis of DHA (omega-3 fatty acid): FADS2 gene polymorphisms and regulation by PPARα. OCL 28 (43). [Google Scholar]
  • Majou D, Dermenghem AL. 2023. DHA (omega-3 fatty acid) and estradiol: key roles in regional cerebral glucose uptake. OCL 30 (22). [Google Scholar]
  • Majou D, Dermenghem AL. 2024a. Effects of DHA (omega-3 fatty acid) and estradiol on amyloid β-peptide regulation in the brain. Brain Res 1823: 148681. [Google Scholar]
  • Majou D, Dermenghem AL. 2024b. DHA (omega-3 fatty acid) increases the action of brain-derived neurotrophic factor (BDNF). OCL 31 (2). [Google Scholar]
  • Martinez M. 1991. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: severe deficiency of docosahexaenoic acid in Zellweger’s and pseudo-Zellweger’s syndromes. World Rev Nutr Diet 66: 87–102. [Google Scholar]
  • Matos M, Augusto E, Oliveira CR, Agostinho P. 2008. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 156 (4): 898–910. [Google Scholar]
  • Maurois P, Rocchi S, Pages N, et al. 2008. The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain. Biomed Pharmacother 62 (4): 259–263. [Google Scholar]
  • Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. 2003. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6 (10): 1072–1078. [Google Scholar]
  • Meldrum BS, Nilsson B. 1976. Cerebral blood flow and metabolic rate early and late in prolonged epileptic seizures induced in rats by bicuculline. Brain 99 (3): 523–542. [Google Scholar]
  • Meng F, Yao L. 2020. The role of inflammation in epileptogenesis. Acta Epileptologica 2: 15. [Google Scholar]
  • Minkeviciene R, Rheims S, Dobszay MB, et al. 2009. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29 (11): 3453–3462. [Google Scholar]
  • Moezifar M, Sayyah M, Zendehdel M, Gavzan H.. 2019. Docosahexaenoic acid prevents resistance to antiepileptic drugs in two animal models of drug-resistant epilepsy. Nutr Neurosci 22 (9): 616–624. [Google Scholar]
  • Moltó-Puigmartí C, Plat J, Mensink RP, et al. 2010. FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk. Am J Clin Nutr 91 (5): 1368–1376. [CrossRef] [PubMed] [Google Scholar]
  • Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (2): 109–142. [PubMed] [Google Scholar]
  • Morris MC, Evans DA, Bienias JL, et al. 2003. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60 (2): 194–200. [Google Scholar]
  • Nakagawa T, Kaneko S. 2013. SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain. Curr Mol Pharmacol 6 (2): 66–73. [Google Scholar]
  • Nakamura MT, Nara TY. 2004. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Ann Rev Nutr 24: 345–376. [CrossRef] [PubMed] [Google Scholar]
  • Nalivaeva NN, Fisk L, Canet Aviles RM, Plesneva SA, Zhuravin IA, Turner AJ. 2003. Effects of prenatal hypoxia on expression of amyloid precursor protein and metallopeptidases in the rat brain. Lett Peptide Sci 10: 455–462. [Google Scholar]
  • Nguyen LN, Ma D, Shui G, et al. 2014. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509 (7501): 503–506. [CrossRef] [PubMed] [Google Scholar]
  • Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (11): 7539–7547. [CrossRef] [PubMed] [Google Scholar]
  • Nielsen J, Courville C. 1951. Role of birth injury and asphyxia in idiopathic epilepsy. Neurology 1: 48–52. [Google Scholar]
  • Okubo Y, Sekiya H, Namiki S, et al. 2010. Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci USA 107 (14): 6526–6531. [Google Scholar]
  • Okuno Y, Matsuda M, Miyata Y, et al. 2010. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. Endocr J 57 (4): 303–309. [Google Scholar]
  • Omrani S, Taheri M, Omrani MD, Arsang-Jang S, Ghafouri-Fard S. 2019. The effect of omega-3 fatty acids on clinical and paraclinical features of intractable epileptic patients: a triple blind randomized clinical trial. Clin Transl Med 2019 8(1): 3. [Google Scholar]
  • O'Neill CM, Minihane AM. 2017. The impact of fatty acid desaturase genotype on fatty acid status and cardiovascular health in adults. Proc Nutr Soc. 76(1): 64–75. [Google Scholar]
  • Ouellet M, Emond V, Chen CT, et al. 2009. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochem Int 55 (7): 476–482. [Google Scholar]
  • Ouyang F, Jiang Z, Chen X, et al. 2021. Is cerebral amyloid-β deposition related to post-stroke cognitive impairment? Transl Stroke Res 12 (6): 946–957. [Google Scholar]
  • Park HG, Kothapalli KSD, Park WJ, et al. 2016. Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 ɑ-linolenic acids for FADS2 mediated Δ6-desaturation. Biochim Biophys Acta 1861 (2): 91–97. [Google Scholar]
  • Paudel YN, Angelopoulou E, Piperi C, Othman I, Shaikh MF. 2020. Revisiting the impact of neurodegenerative proteins in epilepsy: focus on alpha-synuclein, beta-amyloid, and tau. Biology 9 (6): 122. [Google Scholar]
  • Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC. 2013. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 3 (4): 342. [Google Scholar]
  • Pellerin L, Magistretti PJ. 1997. Glutamate uptake stimulates Na+,K+-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J Neurochem 69 (5): 2132–2137. [Google Scholar]
  • Pellerin L, Magistretti PJ. 2003. Food for thought: challenging the dogmas. J Cereb Blood Flow Metab 23 (11): 1282–1286. [CrossRef] [PubMed] [Google Scholar]
  • Perucca P, Scheffer IE, Kiley M. 2018. The management of epilepsy in children and adults. Med J Aust 208 (5): 226–233. [Google Scholar]
  • Perucca E, Bialer M, White HS. 2023. New GABA-targeting therapies for the treatment of seizures and epilepsy: I. Role of GABA as a modulator of seizure activity and recently approved medications acting on the GABA system. CNS Drugs 37 (9): 755–779. [Google Scholar]
  • Pittau F, Grouiller F, Spinelli L, Seeck M, Michel CM, Vulliemoz S. 2014. The role of functional neuroimaging in pre-surgical epilepsy evaluation. Front Neurol 5: 31. [Google Scholar]
  • Plummer S, Van den Heuvel C, Thornton E, Corrigan F, Cappai R. 2016. The neuroprotective properties of the amyloid precursor protein following traumatic brain injury. Aging Dis 7 (2): 163–179. [Google Scholar]
  • Porta N, Vallée L, Lecointe C, et al. 2009. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia 50 (4): 943–948. [Google Scholar]
  • Postnikova TY, Zubareva OE, Kovalenko AA, Kim KK, Magazanik LG, Zaitsev AV. 2017. Status epilepticus impairs synaptic plasticity in rat hippocampus and is followed by changes in expression of NMDA receptors. Biochemistry (Mosc) 82 (3): 282–290. [Google Scholar]
  • Price SA, Held B, Pearson HA. 1998. Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones. NeuroReport 9: 539–545. [Google Scholar]
  • Putnam JC, Carlson SE, DeVoe PW, Barness LA. 1982. The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants. Am J Clin Nutr 36 (1): 106–114. [Google Scholar]
  • Quist A, Doudevski I, Lin H, et al. 2005. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102 (30): 10427–10432. [Google Scholar]
  • Ramsden M, Henderson Z, Pearson HA. 2002. Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status. Brain Res 956: 254–261. [Google Scholar]
  • Reda DM, Abd-El-Fatah NK, Omar T-S. 2015. Fish oil intake and seizure control in children with medically resistant epilepsy. N Am J Med Sci 7 (7): 317–321. [Google Scholar]
  • Reis PA, de Albuquerque CFG, Gutierrez TM, Silva AR, de Castro Faria Neto HC. 2017. Role of nitric oxide synthase in the function of the central nervous system under normal and infectious conditions. In: Saravi SSS, ed. Nitric oxide synthase − simple enzyme-complex roles. London: InTech p. 55–70. [Google Scholar]
  • Riccomagno MM, Kolodkin AL. 2015. Sculpting neural circuits by axon and dendrite pruning. Annu Rev Cell Dev Biol 31: 779–805. [Google Scholar]
  • Rodriguez-Cruz M, Tovar AR, Palacios-González B, Del Prado M, Torres N. 2006. Synthesis of long-chain polyunsaturated fatty acids in lactating mammary gland: role of Delta5 and Delta6 desaturases, SREBP-1, PPARalpha, and PGC-1. J Lipid Res 47 (3): 553–560. [Google Scholar]
  • Romera C, Hurtado O, Mallolas J, et al. 2007. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab 27 (7): 1327–338. [Google Scholar]
  • Romoli M, Sen A, Parnetti L, Calabresi P, Costa C. 2021. Amyloid-β: a potential link between epilepsy and cognitive decline. Nat Rev Neurol 17 (8): 469–485. [Google Scholar]
  • Roy CS, Sherrington CS. 1890. On the regulation of the blood-supply of the brain. J Physiol 11: 85–158. [CrossRef] [PubMed] [Google Scholar]
  • Rzehak P, Heinrich J, Klopp N, et al. 2009. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 101 (1): 20–26. [Google Scholar]
  • Sahlin C, Pettersson FE, Nilsson LN, Lannfelt L, Johansson AS. 2007. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer’s disease. Eur J Neurosci 26 (4): 882–889. [Google Scholar]
  • Samokhna E, Popova I, Malkov A, et al. 2017. Chronic inhibition of brain glycolysis initiates epileptogenesis. J Neurosci Res 95 (11): 2195–2206. [Google Scholar]
  • Schaeffer L, Gohlke H, Müller M, et al. 2006. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15 (11): 1745–1756. [CrossRef] [PubMed] [Google Scholar]
  • Schlanger S, Shinitzky M, Yam D. 2002. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43: 103–104. [Google Scholar]
  • Schurr A, Rigor BM. 1998. Brain anaerobic lactate production: A suicide note or a survival kit? J Dev Neurosci 20 (4-5): 348–357. [CrossRef] [PubMed] [Google Scholar]
  • Scorza FA, Cavalheiro EA, Arida RM, et al. 2009. Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study. Epilepsy Behav 15 (4): 527–528. [Google Scholar]
  • Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR. 2011. Glutamate transporter variants reduce glutamate uptake in Alzheimer’s disease. Neurobiol Aging 32 (3): 553.e1–11. [Google Scholar]
  • Senanayake N, Roman GC. 1993 Epidemiology of epilepsy in developing countries. Bull World Health Org 71(2): 247–258. [Google Scholar]
  • Shankar GM, Li S, Mehta TH, et al. 2008. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14 (8): 837–842. [Google Scholar]
  • Sheng JG, Boop FA, Mrak RE, Griffin WS. 1994. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem 63 (5): 1872–1879. [Google Scholar]
  • Shin EJ, Jeong JH, Chung YH, et al. 2011. Role of oxidative stress in epileptic seizures. Neurochem Int 59 (2): 122–137. [Google Scholar]
  • Sima X, Xu J, Li J, Zhong W, You C. 2014. Expression of β-amyloid precursor protein in refractory epilepsy. 9 (4): 1242–1248. [Google Scholar]
  • Sinclair AJ, Crawford MA. 1972. The incorporation of linolenic and docosahexaenoic acid into liver and brain lipids of developing rats. FEBS Lett 26: 127–129. [CrossRef] [PubMed] [Google Scholar]
  • Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. 1996. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem 271 (2): 1111–1117. [Google Scholar]
  • Smith CD, Carney JM, Starke-Reed PE, et al. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Nat Acad Sci USA 88 (23): 10540–10543. [Google Scholar]
  • Snyder EM, Nong Y, Almeida CG, et al. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8: 1051–1058. [CrossRef] [PubMed] [Google Scholar]
  • Søgaard R, Werge TM, Bertelsen C, et al. 2006. GABA(A) receptor function is regulated by lipid bilayer elasticity. Biochemistry 45 (43): 13118–13129. [Google Scholar]
  • Song J, Li C, Lv Y, Zhang Y, Amakye WK, Mao L. 2017. DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes. 2Nutr Metab (Lond) 14: 52. [Google Scholar]
  • Sontheimer H, Fernandez-Marques E, Ullrich N, Pappas CA, Waxman SG. 1994. Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity. J Neurosci 14(5 Pt 1): 2464–2475. [Google Scholar]
  • Stancill JS, Kasmani MY, Khatun A, Cui W, Corbett JA. 2021. Cytokine and nitric oxide-dependent gene regulation in islet endocrine and nonendocrine cells. Function (Oxf) 3 (1): zqab063. [Google Scholar]
  • Stincone A, Prigione A, Cramer T, et al. 2015. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc 90 (3): 927–963. [Google Scholar]
  • Stobart JL, Lu L, Anderson HD, Mori H, Anderson CM. 2013. Astrocyte-induced cortical vasodilation is mediated by D-serine and endothelial nitric oxide synthase. Proc Natl Acad Sci USA 110 (8): 3149–3154. [CrossRef] [PubMed] [Google Scholar]
  • Stoffel W, Holz B, Jenke B, et al. 2008. Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids. EMBO J 27 (17): 2281–2292. [CrossRef] [PubMed] [Google Scholar]
  • Swanson D, Block R, Mousa SA. 2012. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr 3 (1): 1–7. [Google Scholar]
  • Taha AY, Jeffrey MA, Taha NM, Bala S, Burnham WM. 2010. Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats. Epilepsy Behav 17 (3): 336–343. [Google Scholar]
  • Taha AY, Zahid T, Epps T, et al. 2013. Selective reduction of excitatory hippocampal sharp waves by docosahexaenoic acid and its methyl ester analog ex-vivo. Brain Res 1537: 9–17. [Google Scholar]
  • Takahashi K, Chen L, Sayama M, et al. 2023. Leucine 434 is essential for docosahexaenoic acid-induced augmentation of L-glutamate transporter current. J Biol Chem 299 (1): 102793. [Google Scholar]
  • Tanjung C, Rzehak P, Sudoyo H, et al. 2018. The association of fatty acid desaturase gene polymorphisms on long-chain polyunsaturated fatty acid composition in Indonesian infants. Am J Clin Nutr 108 (5): 1135–1144. [Google Scholar]
  • Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C. 2006. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 1094 (1): 38–46. [Google Scholar]
  • Tosi F, Sartori F, Guarini P, Olivieri O, Martinelli N. 2014. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease. Adv Exp Med Biol 824: 61–81. [CrossRef] [PubMed] [Google Scholar]
  • Treebak JT, Glund S, Deshmukh A, et al. 2006. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55 (7): 2051–2058. [CrossRef] [PubMed] [Google Scholar]
  • Trepanier MO, Taha AY, Mantha RL, et al. 2012. Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses. Epilepsy Res 99 (3): 225–232. [Google Scholar]
  • Tsukada H, Kakiuchi T, Fukumoto D, Nishiyama S, Koga K. 2000. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain Res 862 (1-2): 180–186. [CrossRef] [PubMed] [Google Scholar]
  • Valles SL, Dolz-Gaiton P, Gambini J, et al. 2010. Estradiol or genistein prevent Alzheimer’s disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res 1312: 138–144. [Google Scholar]
  • Van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. 2007. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr 85 (4): 1142–1147. [Google Scholar]
  • Van den Heuvel C, Blumbergs PC, Finnie JW, et al. 1999. Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp Neurol 159 (2): 441–450. [Google Scholar]
  • Volnova A, Tsytsarev V, Ptukha M, Inyushin M. 2020. In vitro and in vivo study of the short-term vasomotor response during epileptic seizures. Brain Sci 10 (12): 942. [Google Scholar]
  • Voss A, Reinhart M, Sankarappa S, Sprecher H. 1991. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266 (30): 19995–20000. [PubMed] [Google Scholar]
  • Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB. 2000. Beta-amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology. J Biol Chem 275: 5626–5632. [CrossRef] [PubMed] [Google Scholar]
  • Wang DY, Fulthorpe R, Liss SN, Edwards EA. 2004. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol 18 (2): 402–411. [CrossRef] [PubMed] [Google Scholar]
  • Wang X, Hu Z, Zhong K. 2021. The role of brain-derived neurotrophic factor in epileptogenesis: an update. Front Pharmacol 12: 758232. [Google Scholar]
  • Wang X, Xiao A, Yang Y, et al. 2022. DHA and EPA prevent seizure and depression-like behavior by inhibiting ferroptosis and neuroinflammation via different mode-of-actions in a Pentylenetetrazole-induced kindling model in mice. Mol Nutr Food Res 66 (22): e2200275. [Google Scholar]
  • Watanabe K, Hara K, Miyazaki S, Hakamada S. 1980. The role of perinatal brain injury in the genesis of childhood epilepsy. Folia Psychiatr Neurol Jpn 34: 227–232. [Google Scholar]
  • Wheaton WW, Chandel NS. 2011. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol 300 (3): C385–393. [Google Scholar]
  • Wiencken AE, Casagrande VA. 1999. Endothelial nitric oxide synthetase (eNOS) in astrocytes: another source of nitric oxide in neocortex. Glia 26 (4): 280–290. [Google Scholar]
  • Xie L, Innis SM. 2008. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 138 (11): 2222–2228. [Google Scholar]
  • Xu W, Fitzgerald S, Nixon RA, Levy E, Wilson DA. 2015. Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer’s disease. Exp Neurol 264: 82–91. [Google Scholar]
  • Yang X, Sheng W, Sun GY, Lee JC. 2011. Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing. Neurochem Int 58 (3): 321–329. [Google Scholar]
  • Yang Y, Wang X, Chen L, et al. 2023. A compared study of eicosapentaenoic acid and docosahexaenoic acid in improving seizure-induced cognitive deficiency in a pentylenetetrazol-kindling young mice model. Mar Drugs 21 (9): 464. [Google Scholar]
  • Yonezawa T, Marasigan CNBB, Matsumiya Y, Maeda S, Motegi T, Momoi Y. 2023. Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study. Open Vet J 13 (7): 942–947. [Google Scholar]
  • Yu SP, Farhangrazi ZS, Ying HS, Yeh CH, Choi DW. 1998. Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death. Neurobiol Dis 5: 81–88. [Google Scholar]
  • Yuen AW, Sander JW, Fluegel D, et al. 2005. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2): 253–258. [Google Scholar]
  • Zhang L, Guo Y, Hu H, Wang J, Liu Z, Gao F. 2015. FDG-PET and NeuN-GFAP immunohistochemistry of hippocampus at different phases of the pilocarpine model of temporal lobe epilepsy. Int J Med Sci 12 (3): 288–294. [Google Scholar]
  • Zhou L, Xiong JY, Chai YQ, et al. 2022. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front Psychiatry 13: 933704. [Google Scholar]
  • Zhu X, Li X, Zhu M, et al. 2018. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation. J Neuroinflammation 15 (1): 221. [Google Scholar]
  • Zylberter Y, Zylberter M. 2017. The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction. J Neurosci Res 95 (11): 2217–2235. [Google Scholar]
  • Zonta M, Angulo MC, Gobbo S, et al. 2003. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6 (1): 43–50. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.